| Teclistamab |
TECLISTAMAB (特立妥单抗 ) |
2119595-80-9 |
| Evinacumab |
Evinacumab |
1446419-85-7 |
| Bococizumab |
Bococizumab |
1407495-02-6 |
| NSC 377363 |
NSC 377363 |
502139-01-7 |
| COH34 |
化合物 T10859 |
906439-72-3 |
| 2-(Acetylamino)-5-chlorobenzenesulfonate Pyridine |
2-(ACETYLAMINO)-5-CHLOROBENZENESULFONATE PYRIDINE |
54981-41-8 |
| GSK620 |
GSK620 |
2088410-46-0 |
| 2-chloro-6,7-dihydro-5H-thiazolo[4,5-f]indole |
2-chloro-6,7-dihydro-5H-thiazolo[4,5-f]indole |
1247879-12-4 |
| 4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- |
VIT-2763 |
2095668-10-1 |
| LOXO-101 (sulfate) |
(3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐 |
1223405-08-0 |
| McMMAE |
马来酰亚胺基己酰-单甲基澳瑞他汀 E |
863971-24-8 |
| Dalbavancin IMpurity - A40926-B0 |
达巴霉素杂质 |
102961-72-8 |
| (3R,3aS,4S,4aS,7R,9aR)-3-Methyl-7-nitro-1-oxo-N,N-diphenyl-1,3,3a,4,4a,5,6,7,8,9a-decahydronaphtho[2,3-c]furan-4-carboxamide |
VORAPAXAR INTERMEDIATE-沃拉帕沙中间体 |
900186-72-3 |
| 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid |
1-((3-氟-4-(甲基氨基甲酰基)苯基)氨基)环丁烷羧酸 |
2227589-22-0 |
| GSK3145095 |
GSK3145095 |
1622849-43-7 |
| TERBUTALINE IMPURITY C |
特布他林EP杂质C |
139508-58-0 |
| ASLAN003 |
ASLAN003 |
1035688-66-4 |
| 2-[5-[3-(5-Carboxypentyl)-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]-1,3-pentadienyl]-3-ethyl-1,1-dimethyl-1H-benz[e]indolium inner salt |
2-[5-[3-(5-羧基戊基)-1,3-二氢-1,1-二甲基-2H-苯并[E]吲哚-2-亚基]-1,3-戊二烯基]-3-乙基-1,1-二甲基-1H-苯并[E]吲哚内盐 |
210834-22-3 |
| DoMperidone EP IMpurity B |
多潘立酮EP杂质B |
1346598-11-5 |
| Alosetron hydrochloride |
盐酸阿洛司琼 |
122852-69-1 |
QQ
微信
